Axa
CTVA icon

Axa’s Corteva CTVA Stock Holding History

Axa’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,904
Closed -$3.2M – 315
2025
Q2 		$3.2M Sell
42,904
-9,717
-18% -$647K 0.01% 660
2025
Q1 		$3.31M Sell
52,621
-8,107
-13% -$501K 0.01% 632
2024
Q4 		$3.46M Buy
60,728
+22,276
+58% +$1.32M 0.01% 641
2024
Q3 		$2.26M Sell
38,452
-115,745
-75% -$6.32M 0.01% 716
2024
Q2 		$8.32M Buy
154,197
+25,645
+20% +$1.41M 0.02% 423
2024
Q1 		$7.41M Sell
128,552
-3,151
-2% -$163K 0.02% 468
2023
Q4 		$6.31M Buy
131,703
+2,906
+2% +$139K 0.02% 494
2023
Q3 		$6.59M Buy
128,797
+278
+0.2% +$14.7K 0.02% 477
2023
Q2 		$7.36M Sell
128,519
-86,657
-40% -$5.06M 0.02% 474
2023
Q1 		$13M Buy
215,176
+11,350
+6% +$693K 0.04% 366
2022
Q4 		$12M Sell
203,826
-947
-0.5% -$59.9K 0.04% 404
2022
Q3 		$11.7M Sell
204,773
-468,662
-70% -$27.3M 0.05% 395
2022
Q2 		$36.5M Buy
673,435
+130
+0% +$7.55K 0.14% 174
2022
Q1 		$38.7M Buy
673,305
+396,330
+143% +$20.3M 0.11% 211
2021
Q4 		$13.1M Sell
276,975
-30,774
-10% -$1.4M 0.03% 436
2021
Q3 		$13M Buy
307,749
+10,579
+4% +$458K 0.04% 431
2021
Q2 		$13.2M Buy
297,170
+29,105
+11% +$1.34M 0.04% 459
2021
Q1 		$12.5M Sell
268,065
-3,446
-1% -$152K 0.04% 462
2020
Q4 		$10.5M Buy
271,511
+104,798
+63% +$3.75M 0.03% 509
2020
Q3 		$4.8M Buy
166,713
+83,775
+101% +$2.36M 0.02% 636
2020
Q2 		$2.22M Buy
82,938
+42,622
+106% +$1.11M 0.01% 807
2020
Q1 		$948K Sell
40,316
-221
-0.5% -$6.08K ﹤0.01% 862
2019
Q4 		$1.2M Sell
40,537
-810
-2% -$21.4K ﹤0.01% 864
2019
Q3 		$1.16M Sell
41,347
-21,286
-34% -$615K ﹤0.01% 963
2019
Q2 		$1.85M Buy
+62,633
New +$1.69M 0.01% 860

Other funds holding CTVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Axa's CTVA Position: Q3 2025 in Review

Axa sold out of Corteva (CTVA) in Q3 2025, closing a stake of 42,904 shares — an estimated $3.2M sold.

Axa first reported a position in CTVA in Q2 2019 and held it in 25 quarters. The position peaked at $38.7M in Q1 2022. 1,394 funds tracked by Wall St. Rank hold CTVA as of Q3 2025.

  • Axa reported no remaining Corteva position as of Q3 2025 after selling out during the quarter.
  • Axa sold 42,904 Corteva shares in Q3 2025, an estimated $3.2M.
  • Axa first reported a position in Corteva in Q2 2019 and held it in 25 quarters.
  • Axa's Corteva position peaked at $38.7M in Q1 2022.
  • 1,394 funds tracked by Wall St. Rank held Corteva as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.